Loading clinical trials...

Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial | Clinical Trials | Clareo Health

COMPLETEDNA

Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial

NCT00355290•Hospital de Clinicas de Porto Alegre

View on ClinicalTrials.gov

Summary

The primary hypothesis of this trial is that changes in oral vitamin K intake, based on simple food registries, may be superior to conventional changes in doses of medications in order to stabilize chronic oral anticoagulation.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients with any clinical indication for chronic oral anticoagulation with one INR level out of target, without a clear clinical cause for INR instability (unplanned changes in coumadin medications, other pharmacological interactions, clinical illnesses and laboratory errors).

Exclusion Criteria

•Clinical evidence of bleeding or thrombosis.
•INR \> 4 or INR \< 1,5.

Locations (1)

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Key Dates

Start Date

August 1, 2006

Completion Date

December 1, 2007

Last Updated

May 8, 2008

Enrollment

114

ESTIMATED participants

Conditions

Blood Coagulation Disorders

Interventions

Changes on Oral Vitamin K Intake

BEHAVIORAL

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

NCT00178594

Blood Coagulation Disorders, InheritedThrombotic Disorder

View study

COMPLETEDPHASE1/PHASE2

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

NCT03734588

Adeno-Associated Virus (AAV)Blood Coagulation Disorder+15 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 8, 2008Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial

Inclusion Criteria

Exclusion Criteria

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

Study Using Plasma for Patients Requiring Emergency Surgery

The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Thrombin Generation in Liver Transplant Surgery

Determination of Fibrin Activity in Plasma on STA-R® Prototype